Global Artificial Insemination Market Research Report: Information by Procedure (Intrauterine Insemination, Intracervical Insemination, and Intratubal Insemination), Product Type (Insemination Kits, Home Conception Devices, and Accessories), End User (Hospitals and Clinics, Fertility Centers, Home Care Settings, and Others), and Region (Americas, Europe, Asia-Pacific, and Middle East & Africa)—Forecast till 2025

ID: MRFR/MED/0711-HCR | February 2021 | Region: Global | 80 pages

The artificial insemination is expected to register 11.8% CAGR during the forecast period of 2019 to 2025 and will achieve USD 1,943 million in 2025 with a market value of USD 1,726 million in 2018. , Artificial insemination is a treatment for infertility. It is a process involving the introduction of semen into the female reproductive tract. Artificial insemination has grown in popularity as infertility becomes more prevalent and more women opt to become single mothers. , Segmentation, The global artificial insemination has been segmented based on procedure, product type, and end-user. The global market, based on procedure, has been segmented into intrauterine insemination, intracervical insemination, and intratubal insemination. The intrauterine insemination sub-segment is expected to be the largest procedure type market as it increases the fertilization rate by inserting sperm inside the women’s uterus to facilitate fertilization. Intrauterine insemination is the most common and non-invasive procedure, which is expected to drive the growth of the global artificial insemination market., The global market, by product type, has been classified into insemination kits, home conception devices, and accessories. Among this, the insemination kits segment is expected to be the fastest-growing segment in terms of value due to the growing geriatric population and is predicted to generate higher revenue during the forecast period. , The global market, based on end-user, has been segmented into hospitals and clinics, fertility centers, home care settings, and others. The fertility centers segment is expected to hold the largest share of the global market during the forecast period. Furthermore, major pharmaceutical companies are working on launching new insemination kits that have conventional benefits. This is expected to drive the growth of the global artificial insemination market., The global market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The artificial insemination market in the Americas has further been branched into North America and Latin America. Within North American, the market is been divided into the US and Canada. The European artificial insemination has been sub-divided into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, Italy, Spain, the UK, and the rest of Western Europe. The artificial insemination in Asia-Pacif

Market Scenario

The artificial insemination is expected to register 11.8% CAGR during the forecast period of 2019 to 2025 and will achieve USD 1,943 million in 2025 with a market value of USD 1,726 million in 2018.

Artificial insemination is a treatment for infertility. It is a process involving the introduction of semen into the female reproductive tract. Artificial insemination has grown in popularity as infertility becomes more prevalent and more women opt to become single mothers.

Segmentation

The global artificial insemination has been segmented based on procedure, product type, and end-user. The global market, based on procedure, has been segmented into intrauterine insemination, intracervical insemination, and intratubal insemination. The intrauterine insemination sub-segment is expected to be the largest procedure type market as it increases the fertilization rate by inserting sperm inside the women’s uterus to facilitate fertilization. Intrauterine insemination is the most common and non-invasive procedure, which is expected to drive the growth of the global artificial insemination market.

The global market, by product type, has been classified into insemination kits, home conception devices, and accessories. Among this, the insemination kits segment is expected to be the fastest-growing segment in terms of value due to the growing geriatric population and is predicted to generate higher revenue during the forecast period.

The global market, based on end-user, has been segmented into hospitals and clinics, fertility centers, home care settings, and others. The fertility centers segment is expected to hold the largest share of the global market during the forecast period. Furthermore, major pharmaceutical companies are working on launching new insemination kits that have conventional benefits. This is expected to drive the growth of the global artificial insemination market.

The global market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The artificial insemination market in the Americas has further been branched into North America and Latin America. Within North American, the market is been divided into the US and Canada. The European artificial insemination has been sub-divided into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, Italy, Spain, the UK, and the rest of Western Europe. The artificial insemination in Asia-Pacific has been segmented into Japan, China, India, South Korea, and Australia. The artificial insemination in the Middle East & Africa has been divided into the Middle East and Africa.

Key Players

The key players operating in the global artificial insemination market are INVO Bioscience, MEDGYN PRODUCTS, INC., FUJIFILM Irvine Scientific., Kitazato Corporation, Rocket Medical plc, Genea Limited, Vitrolife, Rinovum Women's Health, LLC., and HI-TECH Solutions.

Regional Market Summary

Global Artificial Insemination Market Share (%), by Region, 2018

Source: World Health Organization (WHO), Institute of Medicine (IOM)

The market in America is projected to register a steady growth rate during the forecast period owing to the rising technological advancements. Additionally, fertility problems are rising in the US, which ultimately fuels the demand for artificial insemination in the region. For instance, approximately 12% of women of age between 15 and 44 years in the US have difficulty getting pregnant.

The market in Europe is expected to register a significant growth rate during the forecast period. This can be attributed to the unhealthy lifestyle and rising prevalence of infertility. Moreover, delays in pregnancy and changing lifestyles are the major factors driving the growth of the artificial insemination market in Europe.

The market in Asia-Pacific is expected to dominate the artificial insemination market due to the rising prevalence of infertility. For instance, according to the Asian Pacific Journal of Reproduction, in 2019, in China, the rate of infertility is 15–20% in women and 10–12% in men. Moreover, there is a rise in awareness regarding the infertility treatment options, which is expected to drive the growth of the artificial insemination market in the region.

The market in the Middle East & Africa is expected to grow at a substantial rate due to the increase in the infertility rate in this region.

Global Artificial Insemination Market, by Procedure

Intrauterine Insemination

Intracervical Insemination

Intratubal Insemination

Global Artificial Insemination Market by Product Type

Insemination Kits

Home Conception Devices

Accessories

Global Artificial Insemination Market, by End User

Hospital & Clinics

Fertility Centers

Home Care Settings

Others

Global Artificial insemination Market, by Region

Americas
- North America
  - US
  - Canada

Europe
- Western Europe
  - Germany
  - France
  - Italy
  - Spain
  - UK
  - Rest of Western Europe
- Eastern Europe

Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific

Middle East & Africa
- Middle East
- Africa

Intended Audience

Medical Device Companies

Research and Development (R&D) Companies

Government Research Institutes

Academic Institutes and Universities

Venture Capitalists

TABLE OF CONTENTS

1. REPORT PROLOGUE

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

6. GLOBAL ARTIFICIAL INSEMINATION MARKET, BY PROCEDURE

6.1. Overview

6.2. Intrauterine Insemination

Market Estimates & Forecast, by Region, 2019–2025